Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma

Batra, Pete S.; Kern, Robert C.; Tripathi, Anju; Conley, David B.; Ditto, Anne Marie; Haines, G. Kenneth; Yarnold, Paul R.; Grammar, Leslie

doi:10.1097/00005537-200310000-00008

Cited by 164 publications

(110 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar results have been reported by Batra et al (2003), which analysed 17 patients with nasal polyps and bronchial asthma as well as nine patients with ASS-intolerance and bronchial asthma, showing the improvement of bronchial asthma independent of ASS intolerance [19].…”

Section: Discussionsupporting

confidence: 85%

The Impact of Endonasal Endoscopic Sinus Surgery on Patients with Chronic Pulmonary Diseases

et al. 2017

View full text Add to dashboard Cite

Abstract:Introduction: The impact of endoscopic sinus surgery on bronchial asthma has been studied by several groups. According to the latest studies, patients with chronic obstructive pulmonary disease (COPD) seem to have frequent symptoms of chronic rhinosinusitis. Our study compares the impact of endoscopic sinus surgery on both the upper and lower airways of patients with bronchial asthma as well as those with COPD. Methods: This study includes 43 patients (bronchial asthma, n = 32, COPD, n = 11) undergoing surgical treatment for chronic rhinosinusitis at the ENT-Department, University of Homburg (Homburg, Germany). To assess the effect of sinus surgery, the Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) and St. George's Respiratory Questionnaire (SGRQ) were used both pre-and postoperatively. Results: Both SNOT-20 (p < 0.001) and SGRQ (p = 0.021) scores improved significantly after sinus surgery. The postoperative improvement in bronchial asthma and COPD was similar in both groups, indicating no difference of the diseases in regards to postoperative symptom improvement. There was no difference indicated in SNOT-20 GAV or SGRQ when grouping patients by polyps, aspirin (ASS) intolerance, allergies, eosinophilia or previous surgery. Conclusions: The treatment of chronic rhinosinusitis by sinus surgery may help to improve the therapy outcome of patients with bronchial asthma as well as patients with COPD.

show abstract

Section: Discussionsupporting

confidence: 85%

The Impact of Endonasal Endoscopic Sinus Surgery on Patients with Chronic Pulmonary Diseases

et al. 2017

View full text Add to dashboard Cite

show abstract

“…However, symptom profiles differed between the two disease phenotypes, with headache and sleep disturbance being more present in CRSsNP while loss of sense of smell was more bothersome in CRSwNP using VAS scores and EPOS control criteria 17,18.…”

Section: Discussionmentioning

confidence: 99%

Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre

Veen

Seys

Timmermans

et al. 2016

Allergy

126

128

View full text Add to dashboard Cite

RationaleThe European Position Paper on Sinusitis (EPOS) guidelines provide composite criteria to evaluate chronic rhinosinusitis (CRS) control, taking into consideration the severity of patients’ symptoms, aspect of nasal mucosa and medical intake as parameters of CRS control.ObjectivesTo study the degree of CRS control using novel EPOS control criteria at 3–5 years after a functional endoscopic sinus surgery (FESS) and correlate these data to symptoms scores.MethodsAdult CRS patients (n = 560) who had undergone bilateral FESS for chronic inflammatory sinonasal disease 3–5 years prior to the study were included. Patients received a postal questionnaire asking for control items according to EPOS control criteria, visual analogue scale (VAS) scores for total and individual sinonasal symptoms, sinonasal outcome test (SNOT)‐22 and Short Form (SF)‐36 questionnaires.Measurements and main resultsAbout 19.5% of CRS patients were well controlled, with 36.8% of patients being partly controlled and 43.7% uncontrolled. The levels of control corresponded to mean total VAS, SNOT‐22 and SF‐36 scores. Subgroup analysis revealed that female gender, aspirin intolerance and revision FESS were associated with higher prevalence of uncontrolled CRS, whereas allergy, asthma and smoking status did not alter the percentage of patients in each category of control. In 81 patients attending the outpatient clinic, nasal endoscopy changed classification in only four patients (4.9%).ConclusionsBased on the novel EPOS control criteria, at least 40% of CRS patients are uncontrolled at 3–5 years after FESS. Therefore, better treatment strategies leading to higher disease control are warranted in CRS care.

show abstract

“…319,861,862 Using objective and subjective sinonasal and asthma outcome measures, studies have demonstrated significant clinical improvement following ESS. 320,861,[863][864][865][866] In patients with asthma and NPs, ESS was shown to improve asthma severity scores, reduce the need of inhaled corticosteroids and reduce the frequency of asthma-related emergency room visits. 863 Ehnhage et al 864 showed in a prospective randomized trial that patients with CRSwNP had a significant improvement in nasal and lower airway symptoms after ESS.…”

Section: Viiib Crswnp: Comorbid Asthmamentioning

confidence: 99%

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Orlandi

Kingdom

Hwang

et al. 2016

Int Forum Allergy Rhinol

Self Cite

554

888

View full text Add to dashboard Cite

Background:The body of knowledge regarding rhinosinusitis (RS) continues to expand, with rapid growth in number of publications, yet substantial variability in the quality of those presentations. In an effort to both consolidate and critically appraise this information, rhinologic experts from around the world have produced the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS). Methods:Evidence-based reviews with recommendations (EBRRs) were developed for scores of topics, using previously reported methodology. Where existing evidence was insufficient for an EBRR, an evidence-based review (EBR) was produced. The sections were then synthesized and the entire manuscript was then reviewed by all authors for consensus. Results:The resulting ICAR:RS document addresses multiple topics in RS, including acute RS (ARS), chronic RS (CRS) with and without nasal polyps (CRSwNP and CRSsNP), recurrent acute RS (RARS), acute exacerbation of CRS (AE-CRS), and pediatric RS. Conclusion:As a critical review of the RS literature, ICAR:RS provides a thorough review of pathophysiology and evidence-based recommendations for medical and surgical treatment. It also demonstrates the significant gaps in our understanding of the pathophysiology and optimal management of RS. Too o en the foundation upon which these recommendations are based is comprised of lowerlevel evidence. It is our hope that this summary of the evidence in RS will point out where additional research efforts may be directed. C 2016 ARS-AAOA, LLC. Key Words:rhinosinusitis; chronic rhinosinusitis; acute rhinosinusitis; recurrent acute rhinosinusitis; evidence-based medicine; systematic review; endoscopic sinus surgery List of Abbreviations Used

show abstract

Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma

Cited by 164 publications

References 12 publications

The Impact of Endonasal Endoscopic Sinus Surgery on Patients with Chronic Pulmonary Diseases

The Impact of Endonasal Endoscopic Sinus Surgery on Patients with Chronic Pulmonary Diseases

Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

Contact Info

Product

Resources

About